logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

SILKWAVE INC (00471) will resume trading on August 21.

date
08:44 21/08/2026
avatar
GMT Eight
Zhongbo Data (00471) announced that the trading of its shares will resume at 9:00 AM on August 21, 2026.
SILKWAVE INC (00471) announced that its shares will resume trading on August 21, 2026, at 9:00 AM.
Related Articles
HK Stock Market Move | Zhongruan International (00354) surged over 7% after earnings report, with shareholder profit attributable to shareholders for the first half of the year at 350 million yuan, an increase of 11% year-on-year.
HK Stock Market Move | GOLDEN THROAT (06896) fell over 20% after a profit warning, expecting a 40% year-on-year decline in net profit for the first half of the year due to increased selling expenses.
HK Stock Market Move | Luye Pharma (02186) surged over 6% in early trading as the mRNA vaccine LY01620 is set to begin Phase II clinical trials in China.
HK Stock Market Move | Zhongruan International (00354) surged over 7% after earnings report, with shareholder profit attributable to shareholders for the first half of the year at 350 million yuan, an increase of 11% year-on-year.
HK Stock Market Move | GOLDEN THROAT (06896) fell over 20% after a profit warning, expecting a 40% year-on-year decline in net profit for the first half of the year due to increased selling expenses.
HK Stock Market Move | Luye Pharma (02186) surged over 6% in early trading as the mRNA vaccine LY01620 is set to begin Phase II clinical trials in China.
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.